Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Witzke, O' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 30 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Witzke, O; Winterhagen, T; Saller, B; Roggenbuck, U; Lehr, I; Philipp, T; Mann, K; Reinhardt, W
      Transient stimulatory effects on pituitary-thyroid axis in patients treated with interleukin-2

      THYROID
    2. Witzke, O; Wheeler, PR; Barbara, JAJ; Gaspar, MC; Morris, PJ; Wood, KJ
      Suppression mediated by anergic CD4(+) T cells requires stimulation by MHC-peptide complexes and can be induced in the presence of costimulation

      TRANSPLANTATION
    3. Witzke, O; Schmidt, C; Kohnle, M; Lutkes, P; Philipp, T; Heemann, U
      Impact of febrile infections on the long-term function of kidney allografts

      JOURNAL OF UROLOGY
    4. Ensminger, SM; Spriewald, BM; Sorensen, HV; Witzke, O; Flashman, EG; Bushell, A; Morris, PJ; Roe, ML; Rahemtulla, A; Wood, KJ
      Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation

      JOURNAL OF IMMUNOLOGY
    5. Ensminger, SM; Spriewald, BM; Witzke, O; Morrison, K; Van Maurik, A; Morris, PJ; Rose, ML; Wood, KJ
      Intragraft interleukin-4 mRNA expression after short-term CD154 blockade may trigger delayed development of transplant arteriosclerosis in the absence of CD8+T cells

      TRANSPLANTATION
    6. Barbara, JAJ; Turvey, SE; Kingsley, CI; Spriewald, BM; Hara, M; Witzke, O; Morris, PJ; Wood, KJ
      Islet allograft rejection can be mediated by CD4(+) alloantigen experienced, direct pathway T cells of Th1 and Th2 cytokine phenotype

      TRANSPLANTATION
    7. Niimi, PS; Witzke, O; Bushell, A; Hara, M; Morris, PJ; Wood, KJ
      Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: Oraltolerance to alloantigen

      TRANSPLANTATION
    8. Niimi, M; Roelen, DL; Witzke, O; van Rood, JJ; Claas, FHJ; Wood, KJ
      The importance of H-2 haplotype sharing in the induction of specific unresponsiveness by pretransplant blood transfusions

      TRANSPLANTATION
    9. Ensminger, SM; Witzke, O; Spriewald, BM; Morrison, K; Morris, PJ; Rose, ML; Wood, KJ
      CD8(+) T cells contribute to the development of transplant arteriosclerosis despite CD154 blockade

      TRANSPLANTATION
    10. Jones, ND; Van Maurik, A; Hara, M; Spriewald, BM; Witzke, O; Morris, PJ; Wood, KJ
      CD40-CD40 ligand-independent activation of CD8(+) T cells can trigger allograft rejection

      JOURNAL OF IMMUNOLOGY
    11. Heemann, U; Szabo, A; Hamar, P; Muller, V; Witzke, O; Lutz, J; Philipp, T
      Lipopolysaccharide pretreatment protects from renal ischemia/reperfusion injury - Possible connection to an interleukin-6-dependent Pathway

      AMERICAN JOURNAL OF PATHOLOGY
    12. Lutkes, P; Witzke, O; Philipp, T; Schmitt, HJ; Heemann, U
      Immunization and medical recommendations for patients travelling after transplantation

      DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    13. Reinhardt, W; Sauter, V; Jockenhovel, F; Kummer, G; Uppenkamp, M; Witzke, O; Philipp, T; Reinwein, D; Mann, K
      Unique alterations of thyroid function parameters after i.v. administration of alkylating drugs (cyclophosohamide and ifosfamide)

      EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    14. Lutkes, P; Franke, G; Witzke, O; Zimmermann, U; Kohnle, M; Philipp, T; Heemann, U
      Quality of life after renal transplantation. The impact of tacrolimus

      ZENTRALBLATT FUR CHIRURGIE
    15. Fluck, N; Witzke, O; Morris, PJ; Wood, KJ
      Indirect allorecognition is involved in both acute and chronic allograft rejection

      TRANSPLANTATION PROCEEDINGS
    16. WITZKE O; WINTERHAGEN T; REINHARDT W; HEEMANN U; GROSSEWILDE H; KREUZFELDER E; ROGGENDORF M; PHILIPP T
      COMPARISON BETWEEN SUBCUTANEOUS AND INTRAVENOUS INTERLEUKIN-2 TREATMENT IN HIV DISEASE

      Journal of internal medicine
    17. REINHARDT W; BARTELWORTH H; JOCKENHOVEL F; SCHMIDTGAYK H; WITZKE O; WAGNER K; HEEMANN UW; REINWEIN D; PHILIPP T; MANN K
      SEQUENTIAL-CHANGES OF BIOCHEMICAL BONE PARAMETERS AFTER KIDNEY-TRANSPLANTATION

      Nephrology, dialysis, transplantation
    18. WITZKE O; BECKER G; ERHARD J; LUTKES P; SZABO A; PHILIPP T; HEEMANN U
      TACROLIMUS RESCUE THERAPY IN PATIENTS WITH REJECTION AND LONG-TERM DIALYSIS AFTER KIDNEY-TRANSPLANTATION

      Clinical nephrology
    19. KOHNLE M; LUTKES P; WITZKE O; PHILIPP T; HEEMANN U
      CONVERSION TO TACROLIMUS IN CYCLOSPORINE-A TREATED PATIENTS WITH GUM HYPERPLASIA

      Transplantation proceedings
    20. Niimi, M; Hava, M; Witzke, O; Morris, PJ; Wood, KJ
      Donor resting B cells induce indefinite prolongation of fully allogeneic cardiac grafts when delivered with anti-immunoglobulin-D monoclonal antibody: Evidence for tolerogenicity of donor resting B cells in vivo

      TRANSPLANTATION
    21. HEEMANN U; HAMAR P; SZABO A; MULLER V; WITZKE O; SCHADE U; PHILIPP T
      IL-2 DEPENDENT MECHANISMS ARE INVOLVED IN CHRONIC KIDNEY ALLOGRAFT-REJECTION IN RATS

      Journal of the American Society of Nephrology
    22. BECKER G; WITZKE O; FRIEDRICH J; ALBRECHT KH; WAGNER K; PHILIPP T; HEEMANN U
      RESCUE THERAPY WITH TACROLIMUS IN SIMULTANEOUS PANCREAS KIDNEY TRANSPLANTATION/

      Transplant international
    23. WITZKE O; PLENTZ A; SCHAFERS RF; REINHARDT W; HEEMANN U; PHILIPP T
      SIDE-EFFECTS OF RITONAVIR AND ITS COMBINATION WITH SAQUINAVIR WITH SPECIAL REGARD TO RENAL-FUNCTION

      AIDS
    24. WITZKE O; BECKER G; FRANKE G; BINEK M; PHILIPP T; HEEMANN U
      KIDNEY-TRANSPLANTATION IMPROVES QUALITY-OF-LIFE

      Transplantation proceedings
    25. HAMAR P; MULLER V; KOHNLE M; WITZKE O; ALBRECHT KH; PHILIPP T; HEEMANN U
      METABOLIC FACTORS HAVE A MAJOR IMPACT ON KIDNEY ALLOGRAFT SURVIVAL

      Transplantation
    26. WITZKE O; HEEMANN U; THESING A; WOLFHARD U; ERHARD J; PHILIPP T; MICHEL MC
      A COMPARISON OF EMIT AND FPIA METHODS FOR THE DETECTION OF CYCLOSPORINE-A BLOOD-LEVELS - DOES IMPAIRED LIVER-FUNCTION MAKE A DIFFERENCE

      European Journal of Clinical Pharmacology
    27. HEEMANN U; BECKER G; WITZKE O; FRIEDRICH J; WAGNER K; NIEBEL W; PHILIPP T
      TACROLIMUS THERAPY (FK-506) FOLLOWING SIM ULTANEOUS KIDNEY-PANCREAS TRANSPLANTATION

      Nieren- und Hochdruckkrankheiten
    28. BECKER G; WITZKE O; FRIEDRICH J; WAGNER K; HEEMANN U; PHILIPP T
      TACROLIMUS (FK-506) THERAPY IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATION

      Transplantation proceedings
    29. KASSUBEK J; WITZKE O; BONMANN E; MUSCH E
      ALTERNATING IMMUNE THERAPY IN RENAL-CELL CARCINOMA

      Onkologie
    30. WITZKE O; KASSUBEK J; BONMANN E; MUSCH E
      CRYOGLOBULINEMIA - A COMPLICATION OF INFECTIONS DISEASE

      The Clinical investigator


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/10/20 alle ore 20:48:20